No Pharma Money
En Español
News & Reports
Explainers November 18, 2026

“The choice is not between innovation and affordability. Patients need both.”

By P4ADNow Team

P4ADNow CEO Testifies Before Senate Judiciary Committee, Urges Congress To Advance Bipartisan Drug Price Reforms Before Year-End

P4AD CEO Merith Basey’s Opening Testimony: Merith highlighted how patent abuses delay competition and keep prices high for American patients. She shared the experiences of patient advocate Kevin Baker and P4ADNow founder David Mitchell to underscore why patients need both innovation and affordability. Watch the full video here.

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.